Renalytix plc
RNLXY- Exchange
- OTC
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001811115
No open-market purchases or sales by Renalytix plc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesRENXF
13F holders, Q4 2024
Institutional positions in Renalytix plc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 3
- −21 vs. Q3 2024
- Shares held
- 67.1K
- −3.43M (−98.1%) vs. Q3 2024
- Total value
- $13.6K
- −$870.3K (−98.5%) vs. Q3 2024
- New holders
- 0
- 2 more added
- Sold out
- 21
- 1 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNLXY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $2.63K |
| Q2 2025 | 1 | $1.85K |
| Q1 2025 | 1 | $2.20K |
| Q4 2024 | 3 | $13.6K |
| Q3 2024 | 24 | $883.8K |
| Q2 2024 | 26 | $775.1K |
| Q1 2024 | 26 | $3.46M |
| Q4 2023 | 27 | $1.93M |
| Q3 2023 | 26 | $7.19M |
| Q2 2023 | 20 | $10.4M |
| Q1 2023 | 18 | $7.96M |
| Q4 2022 | 22 | $6.46M |
| Q3 2022 | 27 | $5.65M |
| Q2 2022 | 31 | $13.9M |
| Q1 2022 | 35 | $43.8M |
| Q4 2021 | 33 | $95.5M |
| Q3 2021 | 31 | $121.6M |
| Q2 2021 | 41 | $183.5M |
| Q1 2021 | 38 | $152.3M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Renalytix plc; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| XTX Topco Ltd | 32,779 | $6.89K | 0.00% | +12,582+62.3% | Added |
| Baader Bank INC | 24,289 | $4.57K | 0.00% | +9,244+61.4% | Added |
| Ironwood Investment Counsel, LLC | 10,000 | $2.10K | 0.00% | −2,000−16.7% | Reduced |
| Pinnacle Associates Ltd | 0 | $0 | 0.00% | −846,534−100.0% | Sold out |
| Levin Capital Strategies, L.P. | 0 | $0 | 0.00% | −555,000−100.0% | Sold out |
| Tejara Capital Ltd | 0 | $0 | 0.00% | −499,106−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −489,431−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −335,514−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −279,743−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −117,644−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −63,739−100.0% | Sold out |
| Traynor Capital Management, Inc. | 0 | $0 | 0.00% | −61,750−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −53,311−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −43,251−100.0% | Sold out |
| North Star Investment Management Corp. | 0 | $0 | 0.00% | −43,000−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −18,375−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −14,500−100.0% | Sold out |
| Cim, LLC | 0 | $0 | 0.00% | −11,955−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −10,685−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −3,400−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −2,200−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −174−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −1,809−100.0% | Sold out |